Skip to main content
. Author manuscript; available in PMC: 2021 Apr 8.
Published in final edited form as: ACS Appl Mater Interfaces. 2020 Mar 25;12(14):16006–16017. doi: 10.1021/acsami.9b22964

Figure 3.

Figure 3.

In vitro CHX release profiles from nanotube-modified GelMA loaded with distinct nanotube (1, 2, and 5%) concentration and CHX solution concentration (10 and 20%) as a function of time. (a) Cumulative release (in %) and (b) mean drug release (in μg/mL). The results are presented as mean ± standard deviation (SD) (n = 4).